BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1664925)

  • 1. Dopamine D2-receptor mRNA level in rat striatum after chronic haloperidol treatment.
    Matsunaga T; Ohara K; Natsukari N; Fujita M
    Neurosci Res; 1991 Nov; 12(3):440-5. PubMed ID: 1664925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of haloperidol on D2 dopamine receptor subtype mRNA levels in the brain.
    Fishburn CS; David C; Carmon S; Fuchs S
    FEBS Lett; 1994 Feb; 339(1-2):63-6. PubMed ID: 8313980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential plasticity of the dopaminergic D2 receptor mRNA isoforms under haloperidol treatment, as evidenced by in situ hybridization in rat anterior pituitary.
    Arnauld E; Arsaut J; Demotes-Mainard J
    Neurosci Lett; 1991 Sep; 130(1):12-6. PubMed ID: 1836253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation by dopaminergic neurotransmission of dopamine D2 mRNA and receptor levels in the striatum and nucleus accumbens of the rat.
    Angulo JA; Coirini H; Ledoux M; Schumacher M
    Brain Res Mol Brain Res; 1991 Sep; 11(2):161-6. PubMed ID: 1661813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Up-regulation of dopamine D2 receptor mRNA in rat striatum by chronic neuroleptic treatment.
    Rogue P; Hanauer A; Zwiller J; Malviya AN; Vincendon G
    Eur J Pharmacol; 1991 Jun; 207(2):165-8. PubMed ID: 1679015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of haloperidol on expression of dopamine D2 receptor mRNAs in rat brain.
    Srivastava LK; Morency MA; Bajwa SB; Mishra RK
    J Mol Neurosci; 1990; 2(3):155-61. PubMed ID: 1703431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Striatal neurons express increased level of dopamine D2 receptor mRNA in response to haloperidol treatment: a quantitative in situ hybridization study.
    Bernard V; Le Moine C; Bloch B
    Neuroscience; 1991; 45(1):117-26. PubMed ID: 1754061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the expression, transcription and genomic organization of D2 dopamine receptors in outbred and inbred strains of rat.
    Luedtke RR; Artymyshyn RP; Monks BR; Molinoff PB
    Brain Res; 1992 Jul; 584(1-2):45-54. PubMed ID: 1355393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of haloperidol and clozapine on neurotensin gene transcription in rat neostriatum.
    Merchant KM; Dobner PR; Dorsa DM
    J Neurosci; 1992 Feb; 12(2):652-63. PubMed ID: 1531499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transient decrease in rat striatal D2 dopamine receptor mRNA level after acute haloperidol treatment.
    Sakata M; Prasad C
    Brain Res Mol Brain Res; 1992 Jul; 14(3):282-4. PubMed ID: 1331654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic haloperidol affects striatal D2-dopamine receptor reappearance after irreversible receptor blockade.
    Pich EM; Benfenati F; Farabegoli C; Fuxe K; Meller E; Aronsson M; Goldstein M; Agnati LF
    Brain Res; 1987 Dec; 435(1-2):147-52. PubMed ID: 2962698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of clozapine and haloperidol on dopamine receptor mRNA expression in rat striatum and cortex.
    Damask SP; Bovenkerk KA; de la Pena G; Hoversten KM; Peters DB; Valentine AM; Meador-Woodruff JH
    Brain Res Mol Brain Res; 1996 Sep; 41(1-2):241-9. PubMed ID: 8883957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of haloperidol on dopamine receptor gene expression.
    Fox CA; Mansour A; Watson SJ
    Exp Neurol; 1994 Dec; 130(2):288-303. PubMed ID: 7867758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of acute and chronic treatments with clozapine and haloperidol on serotonin (5-HT2) and dopamine (D2) receptors in the rat brain.
    Wilmot CA; Szczepanik AM
    Brain Res; 1989 May; 487(2):288-98. PubMed ID: 2525063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential influence of haloperidol and sulpiride on dopamine receptors and peptide mRNA levels in the rat striatum and pituitary.
    Jaber M; Tison F; Fournier MC; Bloch B
    Brain Res Mol Brain Res; 1994 Apr; 23(1-2):14-20. PubMed ID: 7518029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of D1A and D2 dopamine receptor mRNA during ontogenesis, lesion and chronic antagonist treatment.
    Xu SX; Monsma FJ; Sibley DR; Creese I
    Life Sci; 1992; 50(5):383-96. PubMed ID: 1732708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Irreversible blockade of D2 dopamine receptors by fluphenazine-N-mustard increases glutamic acid decarboxylase mRNA in rat striatum.
    Chen JF; Weiss B
    Neurosci Lett; 1993 Feb; 150(2):215-8. PubMed ID: 8097031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic nicotine use blocks haloperidol-induced increase in striatal D2-dopamine receptor density.
    Prasad C; Spahn SA; Ikegami H
    Biochem Biophys Res Commun; 1989 Feb; 159(1):48-52. PubMed ID: 2522303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in dopamine D1, D2 and D3 receptor mRNA levels in rat brain following antipsychotic treatment.
    Buckland PR; O'Donovan MC; McGuffin P
    Psychopharmacology (Berl); 1992; 106(4):479-83. PubMed ID: 1349752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of effect of chronic dopamine receptor blockade on D2 dopamine receptor mRNA level.
    van Tol HH; Riva M; Civelli O; Creese I
    Neurosci Lett; 1990 Apr; 111(3):303-8. PubMed ID: 1970862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.